Skin Delivery Aspects of Benzoyl Peroxide-Loaded Solid Lipid Nanoparticles for Acne Treatment

References

• EpiCast Report: Acne - Epidemiology Forecast to 2022 . www.prnewswire.com/news-releases/epicast-report-acne---epidemiology-forecast-to-2022–223444231.html
   Google Scholar
• William HC Dellavalle RP Garner S . Acne vulgaris . Lancet379 ( 9813 ), 361 – 372 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Thiboutot D Gollnick H Bettoli V et al. New insights into the management of acne: an update from the global alliance to improve outcomes in acne group . J. Am. Acad. Dermatol.60 ( 5 ), S1 – S50 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Worret WI Fluhr JW . Acne therapy with topical benzoyl peroxide, antibiotics and azelaic acid . J. Dtsch. Dermatol. Ges.4 ( 4 ), 293 – 300 ( 2006 ).
   PubMedGoogle Scholar
• Ramanathan S Hebert AA . Management of acne vulgaris . J. Pediatr. Health Care.25 ( 5 ), 332 – 337 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Mills OH Jr Kligman AM Pochi P Comite H . Comparing 2.5%, 5%, and 10% benzoyl peroxide on inflammatory acne vulgaris . Int. J. Dermatol.25 ( 10 ), 664 – 667 ( 1986 ).
   PubMed Web of Science ®Google Scholar
• Purdy S de Berker D . Acne vulgaris . Clin. Evid.5 , 1714 ( 2011 ).
   Google Scholar
• Fakhouri T Yentzer BA Feldman SR . Advancement in benzoyl peroxide based acne treatment: methods to increase both efficacy and tolerability . J. Drugs Dermatol.8 ( 7 ), 657 – 661 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Krakowski AC Stendardo S Eichenfield LF . Practical considerations in acne treatment and the clinical impact of topical combination therapy . Pediatr. Dermatol.25 ( Suppl. 1 ), 1 – 14 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Swanson JK . Antibiotic resistance of Propionibacterium acnes in acne vulgaris . Dermatol. Nurs.15 ( 4 ), 359 – 362 ( 2003 ).
   PubMedGoogle Scholar
• Hughes BR Norris JF Cunliffe WJ . A double-blind evaluation of topical isotretinoin 0.05%, benzoyl peroxide gel 5% and placebo in patients with acne . Clin. Exp. Dermatol.17 ( 3 ), 165 – 168 ( 1992 ).
   PubMed Web of Science ®Google Scholar
• Patel VB Misra AN Marfatia YS . Preparation and comparative clinical evaluation of gel of benzoyl peroxide for acne . Drug Dev. Ind. Pharm.27 ( 8 ), 863 – 869 ( 2001 ).
   PubMed Web of Science ®Google Scholar
• Fluhr JW Barsom O Gehring W Gloor M . Antibacterial efficacy of benzoyl peroxide in phospholipid liposomes. A vehicle-controlled, comparative study in patients with papulopustular acne . Dermatology198 ( 3 ), 273 – 277 ( 1999 ).
   PubMed Web of Science ®Google Scholar
• Goyal G Garg T Malik B Chauhan G Rath G Goyal AK . Development and characterization of niosomal gel for topical delivery of benzoyl peroxideDrug Deliv. doi:10.3109/10717544.2013.855277 (2013) (Epub ahead of print) .
   PubMed Web of Science ®Google Scholar
• Jelvehgari M Siahi-Shadbad MR Azarmi S Martin GP Nokhodchi A . The microsponge delivery system of benzoyl peroxide: preparation, characterization and release studies . Int. J. Pharm.308 ( 1–2 ), 124 – 132 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Embil K Nacht S . The microsponge delivery system (MDS): a topical delivery system with reduced irritancy incorporating multiple triggering mechanisms for the release of actives . J. Microencapsul.13 ( 5 ), 575 – 588 ( 1996 ).
   PubMed Web of Science ®Google Scholar
• Nokhodchi A Jelvehgari M Siahi MR Mozafari MR . Factors affecting the morphology of benzoyl peroxide microsponges . Micron38 ( 8 ), 834 – 840 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Wester RC Patel R Nacht S Leyden J Melendres J Maibach H . Controlled release of benzoyl peroxide from a porous microsphere polymeric system can reduce topical irritancy . J. Am. Acad. Dermatol.24 ( 5 Pt 1 ), 720 – 726 ( 1991 ).
   PubMed Web of Science ®Google Scholar
• Ridolfi DM Marcato PD Justo GZ Cordi L Machado D Durán N . Chitosan-solid lipid nanoparticles as carriers for topical delivery of tretinoin . Colloids Surf. B. Biointerfaces93 , 36 – 40 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Vaghasiya H Kumar A Sawant K . Development of solid lipid nanoparticles based controlled release system for topical delivery of terbinafine hydrochloride . Eur. J. Pharm. Sci.49 ( 2 ), 311 – 322 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Chen-yu G Chun-fen Y Qi-lu L Qi T Yan-wei X Wei-na L Guang-xi Z . Development of a quercetin loaded nanostructured lipid carrier formulation for topical delivery . Int. J. Pharm.430 ( 1–2 ), 292 – 298 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Souto EB Müller RH . Cosmetic features and applications of lipid nanoparticles (SLN, NLC) . Int. J. Cosmet. Sci.30 ( 3 ), 157 – 165 ( 2008 ).
   PubMedGoogle Scholar
• Mehnert W Mäder K . Solid lipid nanoparticles: production, characterization and applications . Adv. Drug Deliv. Rev.47 ( 2–3 ), 165 – 196 ( 2001 ).
   PubMed Web of Science ®Google Scholar
• Pardeike J Hommoss A Müller RH . Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products . Int. J. Pharm.366 ( 1–2 ), 170 – 184 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Padamwar MN Pokharkar VB . Development of vitamin loaded topical liposomal formulation using factorial design approach: drug deposition and stability . Int. J. Pharm.320 ( 1–2 ), 37 – 44 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• de Vringer T . EP-91200664 ( 1992 ).
   Google Scholar
• Draize JH Woodard G . Calvary , HO . Methods for the study of irritation and toxicity of substances applied topically to the skin and mucus membranes . J. Pharmacol. Exp. Ther.1 , 377 – 390 ( 1944 ).
   Google Scholar
• Naithani V Kumar S Srivastava SM Pathak N Chaudhary M . An evaluation of antimicrobial efficacy of acano against some acne causing microorganisms . Int. J. Drug Dev. Res.2 ( 1 ), 134 – 140 ( 2010 ).
   Google Scholar
• Misra A Kalariya M Padhi BK Chougule M . Methotrexate-loaded solid lipid nanoparticles for topical treatment of psoriasis: formulation & clinical implications . Drug Dev. Deliv.4 ( 8 ), ( 2004 ).
   Google Scholar
• Noriega-Pelaez EK Mendoza-Munoz N Ganem-Quintanar A Quintanar-Guerrero D . Optimization of the emulsification and solvent displacement method for the preparation of solid lipid nanoparticles . Drug Dev. Ind. Pharm.37 ( 2 ), 160 – 166 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Liu J Hu W Chen H Ni Q Xu H Yang X . Isotretinoin-loaded with solid lipid nanoparticles with skin targeting for topical delivery . Int. J. Pharm.328 ( 2 ), 191 – 195 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Levy MY Schutze W Fuhrer C Benita S . Characterization of diazepam submicron emulsion interface: role of oleic acid . J. Microencapsul.11 ( 1 ), 79 – 92 ( 1994 ).
   PubMed Web of Science ®Google Scholar
• Yang T Cui FD Choi MK et al. Enhanced solubility and stability of PEGylated liposomal paclitaxel: in vitro and in vivo evaluation . Int. J. Pharm.338 ( 1–2 ), 317 – 326 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Guadalupe Nava Elizabeth Pinon Luis Mendoza Nestor Mendoza David Quintanar Adriana Ganem . Formulation and in vitro, ex vivo and in vivo evaluation of elastic liposomes for transdermal delivery of ketorolac tromethamine . Pharmaceutics3 ( 4 ) 954 – 970 ( 2011 ).
   PubMedGoogle Scholar
• Mandpe L Pokharkar V . Targeted brain delivery of iloperidone nanostructured lipid carriers following intranasal administration: in vivo pharmacokinetics and brain distribution studies . J. Nanopharm. Drug Deliv.1 ( 2 ), 212 – 225 ( 2013 ).
   Google Scholar
• Jenning V Gohla SH . Encapsulation of retinoids in solid lipid nanoparticles (SLN) . J. Microencapsul.18 ( 2 ), 149 – 158 ( 2001 ).
   PubMed Web of Science ®Google Scholar
• Lu KT Chen TC Hu KH . Investigation of the decomposition reaction and dust explosion characteristics of crystalline benzoyl peroxides . J. Hazard. Mater.161 ( 1 ), 246 – 256 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Maia CS Mehnert W Schäfer-Korting M . Solid lipid nanoparticles as drug carriers for topical glucocorticoids . Int. J. Pharm.196 ( 2 ), 165 – 167 ( 2000 ).
   PubMed Web of Science ®Google Scholar
• Kumar VV Chandrasekar D Ramakrishna S Kishan V Rao YM Diwan PV . Development and evaluation of nitrendipine loaded solid lipid nanoparticles: influence of was and glyceride lipids on plasma pharmacokinetics . Int. J. Pharm.335 ( 1–2 ), 167 – 175 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Tiyaboonchai W Tungpradit W Plianbangchang P . Formulation and characterization of curcuminoids loaded solid lipid nanoparticles . Int. J. Pharm.337 ( 1–2 ), 299 – 306 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Vivek K Reddy H Murthy RS . Investigations of the effect of the lipid matrix on drug entrapment, in vitro release, and physical stability of olanzapine-loaded solid-lipid nanoparticles . AAPS PharmSciTech.8 ( 4 ), E 83 ( 2007 ).
   Web of Science ®Google Scholar
• Vaghasiya H Kumar A Sawant K . Development of solid lipid nanoparticles based controlled release system for topical delivery of terbinafine hydrochloride . Eur. J. Pharm Sci.49 ( 2 ), 311 – 322 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Wissing S Lippacher A Müller R . Investigations on the occlusive properties of solid lipid nanoparticles (SLN) . J. Cosmet. Sci.52 ( 5 ), 313 – 324 ( 2001 ).
   PubMed Web of Science ®Google Scholar
• Pardeike J . Nanosuspensions and nanostructured lipid carriers for dermal application . PhD Dissertation,Freie UniversitätBerlin, Germany ( 2008 ).
   Google Scholar
• Cevc G . Lipid vesicles and other colloids as drug carriers on the skin . Adv. Drug Deliv. Rev.56 ( 5 ), 675 – 711 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• William AC Barry BW . Penetration enhancers . Adv. Drug Deliv. Rev.56 ( 5 ), 603 – 618 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Pople PV Singh KK . Development and evaluation of topical formulation containing solid lipid nanoparticles of vitamin A . AAPS Pharm. Sci. Tech.7 ( 4 ), 91 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Jenning V Gysler A Schäfer-Korting M Gohla SH . Vitamin A loaded solid lipid nanoparticles for topical use: occlusive properties and drug targeting to the upper skin . Eur. J. Pharm. Biopharm.49 ( 3 ), 211 – 218 ( 2000 ).
   PubMed Web of Science ®Google Scholar
• Raza K Singh B Singal P Wadhwa S Katare OP . Systematically optimized biocompatible isotretinoin-loaded solid lipid nanoparticles (SLNs) for topical treatment of acne . Colloids Surf. B. Biointerfaces105 , 67 – 74 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Raza K Singh B Singla S et al. Nanocolloidal carriers of isotretinoin: antimicrobial activity against Propionibacterium acnes and dermatokinetic modeling . Mol. Pharmaceutics10 ( 5 ), 1958 – 1963 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Pannu J McCarthy A Martin A et al. In vitro anti-bacterial activity of NB-003 against Propionibacterium acnes . Antimicrob. Agents Chemother.55 ( 9 ), 4211 – 4217 ( 2011 ).
   PubMed Web of Science ®Google Scholar